IngentaConnect Myeloid suppressor cell-associated immune dysfunction in CSA1M fi...

Authors: Zhou, Ru¹; He, Pei-Lan¹; Ren, Yong-Xin¹; Wang, Wen-Hai²; Zhou, Rong-Yao²; Wan, Hua²; Ono, Shiro³; Fujiwara, Hiromi³; Zuo, Jian-Ping

Source: Cancer Science, Volume 98, Number 6, June 2007 , pp. 882-889(8)

Publisher: Blackwell Publishing

Abstract:

CSA1M tumor-bearing mice exhibited a severe immune dysfunction but the underlying mechanism remained unclear. In this study, we demonstrated that the myeloid suppressor cell (Mac-1⁺Gr-1⁺ cells)-(MSC) related T cell immunosuppression in this tumor-bearing model. In mice at the late stage of CSA1M tumor-bearing (Late TB [8-10 weeks after cell inoculation in male BALB/c mice]), the percentages for CD4⁺ and CD8⁺ T cells decreased but Mac-1⁺ cells increased in spleens with severe splenomegaly. There was no deficit for concanavalin A-induced CD4⁺ and CD8⁺ T cell proliferation, interferon-γ (IFN-γ) and interleukin (IL)-4 production, but delayed-type hypersensitivity reaction were attenuated. Analysis of cytokine production in unfractionated spleen cells showed a significant reduction of IFN-γ and a marked increase of IL-10 and IL-4. In Late-TB mice, splenic MSC number intensively accumulated; the mRNA expressions of the signal transducer and activator of transcription 1, interferon regulatory factor 1 (IRF-1), and inducible nitric-oxide synthase (iNOS) were enhanced in MSC; the nitric oxide production and arginase enzyme activity increased in MSC as well. Furthermore, the concanavalin A-induced T cell proliferation was inhibited in the presence of lipopolysaccharide- or IFN-γ-activated MSC from Late-TB mice, which could be reversed by the iNOS specific inhibitor L-NMMA. iNOS seemed to be required more than arginase for the suppressive activity of MSC. Taken together, our results suggest that the immune dysfunction in tumor-bearing mice might be causally associated with the accumulation of MSC and its tumor-favoring property. (Cancer Sci 2007; 98: 882-889)

Document Type: Research article

DOI: 10.1111/j.1349-7006.2007.00465.x

Affiliations: 1: Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203; 2: Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; 3: Department of Oncology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka 565-0871, Japan

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice